Cargando…

Phenotypic alteration of CD8(+) T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming

Immunosuppression is a prevalent clinical feature in chronic lymphocytic leukemia (CLL) patients, with many patients demonstrating increased susceptibility to infections as well as increased failure of an antitumor immune response. However, much is currently not understood regarding the precise mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiazhu, Xu, Xiaojing, Lee, Eun-Joon, Shull, Austin Y., Pei, Lirong, Awan, Farrukh, Wang, Xiaoling, Choi, Jeong-Hyeon, Deng, Libin, Xin, Hong-Bo, Zhong, Wenxun, Liang, Jinhua, Miao, Yi, Wu, Yujie, Fan, Lei, Li, Jianyong, Xu, Wei, Shi, Huidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130028/ https://www.ncbi.nlm.nih.gov/pubmed/27302925 http://dx.doi.org/10.18632/oncotarget.9941

Ejemplares similares

RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia
por: Shull, Austin Y., et al.
Publicado: (2015)

Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia
por: Pan, Bihui, et al.
Publicado: (2022)

Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
por: Gao, Rui, et al.
Publicado: (2023)

Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia
por: Xu, Zhangdi, et al.
Publicado: (2023)

Epigenetic Regulation of B Lymphocyte Differentiation, Transdifferentiation, and Reprogramming
por: Barneda-Zahonero, Bruna, et al.
Publicado: (2012)

Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis
por: Wu, Wei, et al.
Publicado: (2019)

NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases
por: Zou, Yixin, et al.
Publicado: (2018)

Epigenetic reprogramming during the maternal‐to‐zygotic transition
por: Chen, Yurong, et al.
Publicado: (2023)

Exploring the significance of PAK1 through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia
por: Wu, Zijuan, et al.
Publicado: (2022)

Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies
por: Gu, Danling, et al.
Publicado: (2021)

A simplified prognostic score for T-cell large granular lymphocyte leukaemia
por: Liu, Hailing, et al.
Publicado: (2023)

Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
por: Bugler, Jane, et al.
Publicado: (2019)

t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review
por: Chen, Weifeng, et al.
Publicado: (2016)

Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study
por: Wu, Jiazhu, et al.
Publicado: (2021)

Epigenetic reprogramming in the mammalian germline
por: Hsu, Fei-Man, et al.
Publicado: (2015)

Age reprogramming and epigenetic rejuvenation
por: Singh, Prim B., et al.
Publicado: (2018)

Cellular reprogramming and epigenetic rejuvenation
por: Simpson, Daniel J., et al.
Publicado: (2021)

Epigenetic Trajectories of Aging and Reprogramming
por: Niimi, Peter, et al.
Publicado: (2021)

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
por: Tang, Jing, et al.
Publicado: (2023)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
por: Yu, Xilan, et al.
Publicado: (2018)

Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming
por: Tiemann, Ulf, et al.
Publicado: (2015)

98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia
por: Shi, Ke, et al.
Publicado: (2019)

Epigenetic reprogramming in the porcine germ line
por: Hyldig, Sara MW, et al.
Publicado: (2011)

Epigenetic Control of Reprogramming and Cellular Differentiation
por: Latella, Lucia, et al.
Publicado: (2012)

Epigenetic reprogramming in the epithelial-to-mesenchymal transition
por: Hoang, Stephen, et al.
Publicado: (2012)

Epigenetic reprogramming in the porcine germ line
por: Hyldig, Sara MW, et al.
Publicado: (2011)

Epigenetic reprogramming in liver fibrosis and cancer()
por: Wilson, Caroline L., et al.
Publicado: (2017)

Reprogramming, oscillations and transdifferentiation in epigenetic landscapes
por: Kaity, Bivash, et al.
Publicado: (2018)

Editorial: Epigenetic Reprogramming and Cancer Development
por: Brown, Geoffrey, et al.
Publicado: (2020)

Hypoxia in Cell Reprogramming and the Epigenetic Regulations
por: Nakamura, Nariaki, et al.
Publicado: (2021)

Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2020)

Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition
por: McDonald, Oliver G., et al.
Publicado: (2011)

PB1946: NOTCH PATHWAY MUTATION CONTRIBUTES TO INFERIOR PROGNOSIS IN HBV-INFECTED CHRONIC LYMPHOCYTIC LEUKEMIA
por: Shang, Chunyu, et al.
Publicado: (2023)

The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
por: Jiang, Aiwen, et al.
Publicado: (2022)

Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming
por: Nickerson, Jeffrey A., et al.
Publicado: (2017)

Epigenetic Landscapes Explain Partially Reprogrammed Cells and Identify Key Reprogramming Genes
por: Lang, Alex H., et al.
Publicado: (2014)

Reprogramming of Cell Fate During Root Regeneration by Transcriptional and Epigenetic Networks
por: Jing, Tingting, et al.
Publicado: (2020)

Generation of induced cardiac progenitor cells via somatic reprogramming
por: Xu, Jianyong, et al.
Publicado: (2017)

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
por: Xu, Xuemeng, et al.
Publicado: (2023)

Epigenetic reprogramming in the mammalian embryo: struggle of the clones
por: Mann, Mellissa RW, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_t4e8tm3gh81a8biqqkf1a9csg0